Small molecule, peptide, New Chemical Entity (NCE), VAL201 peptide re-purposed towards non-cancerous cell proliferation.
Mechanism of action: Inhibition of androgen activation of SRC kinase
Primary Indication: Endometriosis;
Developed in-house by ValiRx, under evaluation by an undisclosed Japanese Pharmaceutical Company
Published research: Pimping up Drugs Recovered, Superannuated and Under Exploited Drugs - An Introduction to the Basics of Drug Reprofiling: Suzanne J. Dilly, George S. Morris. Curr Drug Discov Technol. 2017 Jun; 14(2): 121–126.